The discovery that PD-L1 overexpression on a mouse mastocytoma cell line inhibits CD8+ T cell cytolytic function by ligating PD-1, supported the theory that activation of the PD-1/PD-L1 pathway can decrease immune responses for malignancies, allowing increased tumor growth and invasiveness. This evidence concerns the gene PDCD1 and mastocytoma.